🔎 Trials Near Me

Início › Câncer Metastático › Oregon › Portland

Ensaios clínicos de Câncer Metastático em Portland, OR

29 estudos para Câncer Metastático estão buscando participantes em locais em Portland e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

RecrutandoFase 3
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecrutandoFase 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Oregon Health and Science University, Portland
Todas as idades · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecrutandoFase 1/2
  • Oregon Health & Science University (OHSU), Portland
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecrutandoFase 1
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT05382559

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

RecrutandoFase 1
  • ALX Center 6, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

RecrutandoFase 2/3
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06943755

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

RecrutandoFase 1/2
  • Oregon Health & Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05875168

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

RecrutandoFase 3
  • Kaiser Permanente Interstate Medical Office Central, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

RecrutandoFase 2
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07007559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

RecrutandoFase 2/3
  • OHSU Center for Health & Healing 1, Portland
  • Oregon Health and Science University, Portland
  • OSHU Center for Health and Healing 2, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RecrutandoFase 3
  • Northwest Cancer Specialists, P.C., Portland
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

RecrutandoFase 1
  • Providence Portland Medical Center, Portland
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07543055

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecrutandoFase 3
  • Providence Portland Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RecrutandoFase 3
  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
  • e mais 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RecrutandoFase 3
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RecrutandoFase 1/2
  • Northwest Cancer Specialists, P.C., Portland
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07227415

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecrutandoFase 3
  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

RecrutandoFase 2
  • Research Site, Portland
Idades de 18 a 130 · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecrutandoFase 1/2
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study of MGC026 in Participants With Advanced Solid Tumors

RecrutandoFase 1
  • Providence Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RecrutandoFase 1/2
  • Oregon Health & Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RecrutandoFase 3
  • Research Site, Portland
Idades 18 e acima · Mulheres · Atualizado em 29 de jul. de 2026 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

RecrutandoFase 1
  • Investigative Site #121, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT06974110

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

RecrutandoFase 1/2
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT06320405

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

RecrutandoFase 2
  • VA Portland Health Care System, Portland
Idades 18 e acima · Homens · Atualizado em 15 de jun. de 2026 · NCT05422911

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

RecrutandoFase 4
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT07405086

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

RecrutandoFase 1
  • Providence Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 6 de mar. de 2026 · NCT06171750

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

RecrutandoFase 3
  • Oregon Health & Science University Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 6 de fev. de 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecrutandoEstudo observacional
  • Massive Bio SYNERGY-AI site, Portland
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Ensaios de Câncer Metastático em outras cidades

Outros estudos em Portland

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.